Robert Ng is an accomplished professional with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Executive Director of Vector Engineering and Delivery at Lilly Gene Therapy since 2024, Robert has played significant roles in various organizations, including serving as Head of Genetic Technology and Innovation at Akouos since January 2018. Previous positions include Scientist at CRISPR Therapeutics and BioMarin Pharmaceutical Inc., and a background in research as a Postdoctoral Fellow at Dana-Farber Cancer Institute and as a Graduate Research Assistant at the University of Florida. Robert holds an Executive MBA and a Master of Science in Healthcare Leadership from Cornell Johnson Graduate School of Management and Weill Cornell Graduate School of Medical Sciences, respectively, in addition to a PhD in Biochemistry and Molecular Biology from the University of Florida and a Bachelor's degree in Agricultural Chemistry from National Taiwan University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices